טימנטין 3.2 ג'

Nazione: Israele

Lingua: ebraico

Fonte: Ministry of Health

Principio attivo:

CLAVULANIC ACID AS POTASSIUM 200 MG/VIAL; TICARCILLIN DISODIUM 3 G/VIAL

Commercializzato da:

GLAXO SMITH KLINE (ISRAEL) LTD

Codice ATC:

J01CR50

Forma farmaceutica:

POWDER FOR SOLUTION FOR INFUSION

Via di somministrazione:

I.V

Prodotto da:

SMITHKLINE BEECHAM PLC, UK

Gruppo terapeutico:

COMBINATIONS OF PENICILLINS

Indicazioni terapeutiche:

Timentin is an injectable antibiotic agent with a broad spectrum of bactericidal activity against a wide range of Gram-positive and Gram-negative, aerobic and anaerobic bacteria. The presence of clavulanate in the formulation extends the spectrum of activity of ticarcillin to include many beta-lactamase producing bacteria normally resistant to ticarcillin and other beta-lactam antibiotics. Timentin is indicated for the treatment of infections in which susceptible organisms have been detected or are suspected. Typical indications include: severe infections in hospitalised patients and proven or suspected infections in patients with impaired or suppressed host defences including: septicaemia, bacteraemia, peritonitis, intra-abdominal sepsis, post-surgical infections, bone and joint infections, skin and soft tissue infections, respiratory tract infections, serious or complicated renal infections (e.g. pyelonephritis), ear, nose and throat infections.

Data dell'autorizzazione:

2010-10-01